US90238J1034 - Common Stock
TYME TECHNOLOGIES INC
NASDAQ:TYME (9/16/2022, 7:00:02 PM)
After market: 0.2852 -0.03 (-8.21%)0.3107
+0.02 (+8.07%)
Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. The company is headquartered in Bedminster, New Jersey and currently employs 13 full-time employees. The company went IPO on 2012-05-25. TYME's lead drug product, SM-88, is an oral investigational modified proprietary tyrosine derivative that interrupt the metabolic processes of cancer cells by breaking down the cells key defenses and leading to cell death through oxidative stress and exposure to the body's natural immune system. TYME is focused on evaluating its preclinical pipeline of novel CMBT programs, and TYME-19 as a potential therapeutic for SARS CoV-2 diseases. Its preclinical pipeline programs SM-88i, TYME-18, TYME-T and TYME-19. The firm is also developing SM-88i, an injectable formulation of SM-88 for the treatment of multiple oncology indications and TYME-18 for the treatment of solid tumors. The firm is utilizing its metabolism-based technology and is developing TYME-19 as a potential therapeutic for coronavirus, the virus that causes Covid-19.
TYME TECHNOLOGIES INC
1 Pluckemin Way - Suite 103
Bedminster NEW JERSEY 07921
P: 12124612315.0
CEO: Richard Cunningham
Employees: 13
Website: https://www.tymeinc.com/
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday and what's moving them!
-- Combined Company to Trade on Nasdaq Under Ticker “SYRS” ---- Syros Announces 1-for-10 Reverse Stock Split of Common Stock -- CAMBRIDGE, Mass. and...
Investors can start off the day with a breakdown of the biggest pre-market stock movers for Tuesday and the news moving those shares!
BEDMINSTER, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the “Company”), today announced that independent...
Here you can normally see the latest stock twits on TYME, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: